PubMed:23580652 / 1488-1751 JSONTXT

{"project":"sentences","denotations":[{"id":"T10","span":{"begin":0,"end":263},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A 3-month subcutaneous treatment of APPsw(+/0) mice with LRPIV-D3674G (40 μg/kg/day) reduced Aβ40 and Αβ42 levels in the hippocampus, cortex, and cerebrospinal fluid by 60-80% and improved cerebral blood flow responses and hippocampal function at 9 months of age."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T6","span":{"begin":121,"end":132},"obj":"http://purl.obolibrary.org/obo/MAT_0000114"},{"id":"T7","span":{"begin":146,"end":165},"obj":"http://purl.obolibrary.org/obo/MAT_0000499"},{"id":"T8","span":{"begin":198,"end":203},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T9","span":{"begin":198,"end":203},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"A 3-month subcutaneous treatment of APPsw(+/0) mice with LRPIV-D3674G (40 μg/kg/day) reduced Aβ40 and Αβ42 levels in the hippocampus, cortex, and cerebrospinal fluid by 60-80% and improved cerebral blood flow responses and hippocampal function at 9 months of age."}

{"project":"NCBITAXON","denotations":[{"id":"T8","span":{"begin":47,"end":51},"obj":"OrganismTaxon"},{"id":"T9","span":{"begin":121,"end":132},"obj":"OrganismTaxon"}],"attributes":[{"id":"A8","pred":"db_id","subj":"T8","obj":"10088"},{"id":"A9","pred":"db_id","subj":"T9","obj":"72046"}],"text":"A 3-month subcutaneous treatment of APPsw(+/0) mice with LRPIV-D3674G (40 μg/kg/day) reduced Aβ40 and Αβ42 levels in the hippocampus, cortex, and cerebrospinal fluid by 60-80% and improved cerebral blood flow responses and hippocampal function at 9 months of age."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T15","span":{"begin":121,"end":132},"obj":"Body_part"},{"id":"T18","span":{"begin":134,"end":140},"obj":"Body_part"},{"id":"T19","span":{"begin":146,"end":165},"obj":"Body_part"},{"id":"T20","span":{"begin":198,"end":203},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0001954"},{"id":"A16","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0002421"},{"id":"A17","pred":"uberon_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/UBERON_0002961"},{"id":"A18","pred":"uberon_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/UBERON_0001851"},{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"A 3-month subcutaneous treatment of APPsw(+/0) mice with LRPIV-D3674G (40 μg/kg/day) reduced Aβ40 and Αβ42 levels in the hippocampus, cortex, and cerebrospinal fluid by 60-80% and improved cerebral blood flow responses and hippocampal function at 9 months of age."}

{"project":"Anatomy-MAT","denotations":[{"id":"T6","span":{"begin":121,"end":132},"obj":"Body_part"},{"id":"T7","span":{"begin":146,"end":165},"obj":"Body_part"},{"id":"T8","span":{"begin":198,"end":203},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"mat_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MAT_0000114"},{"id":"A7","pred":"mat_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MAT_0000499"},{"id":"A8","pred":"mat_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A9","pred":"mat_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"A 3-month subcutaneous treatment of APPsw(+/0) mice with LRPIV-D3674G (40 μg/kg/day) reduced Aβ40 and Αβ42 levels in the hippocampus, cortex, and cerebrospinal fluid by 60-80% and improved cerebral blood flow responses and hippocampal function at 9 months of age."}